In the secondary analysis, the much less conservative but clinically meaningful criterion of stable reaction (defined for a 50% or more reduction in MADRS from baseline for 2 weeks) was used. Of the patients who obtained steady response, twenty five.8% inside the esketamine group and fifty seven.6% while in the https://malcolmg455apd1.wikienlightenment.com/user